{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06031194",
            "orgStudyIdInfo": {
                "id": "OSU-22305"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2023-03467",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                }
            ],
            "organization": {
                "fullName": "Ohio State University Comprehensive Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma",
            "officialTitle": "Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "pharmacogenomics-effects-on-high-dose-methotrexate-clearance-in-patients-with-diffuse-large-b-cell-lymphoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-31",
            "studyFirstSubmitQcDate": "2023-09-08",
            "studyFirstPostDateStruct": {
                "date": "2023-09-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-30",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Narendranath Epperla",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Ohio State University Comprehensive Cancer Center"
            },
            "leadSponsor": {
                "name": "Ohio State University Comprehensive Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study evaluates pharmacogenomic effects on high-dose methotrexate clearance in patients with diffuse large B-cell lymphoma.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. To identify SNPs associated with delayed MTX clearance. II. To explore any association between SNPs and increased toxicity.\n\nOUTLINE: This is an observational study.\n\nParticipants undergo blood sample collection and have their medical records reviewed on study."
        },
        "conditionsModule": {
            "conditions": [
                "Central Nervous System Lymphoma",
                "Diffuse Large B-Cell Lymphoma"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Observational",
                    "description": "Participants undergo blood sample collection and have their medical records reviewed on study.",
                    "interventionNames": [
                        "Other: Non-Interventional Study"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Non-Interventional Study",
                    "description": "Non-interventional study",
                    "armGroupLabels": [
                        "Observational"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "SNPs (single nucleotide polymorphisms) associated with delayed MTX clearance",
                    "description": "Determine the SNPs associated with delayed methotrexate clearance",
                    "timeFrame": "Up to 24 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* \\* Adult (age \u2265 18 years at diagnosis)\n\n  * Diagnosis of DLBCL or PCNSL\n  * Planned to undergo treatment with HDMTX (\u2265 3 g/m\\^2) at the James Cancer Hospital.\n\nNote: patients with CKD are eligible to participate regardless of eGFR provided the treating physician is planning a dose of HDMTX of at least 3 g/ m\\^2.\n\n* Ability to provide informed consent.\n\nExclusion Criteria:\n\n* \\* Patients with a \"currently active\" second malignancy that, in the opinion of the principal investigator, will interfere with patient participation, or confound data interpretation\n\n  * Pregnancy (positive serum or urine pregnancy test), lactating or breast feeding\n  * Prisoners or incarcerated patients\n  * Total bilirubin \\> 5 mg/dL",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patients with DLBCL or primary CNS lymphoma planned to undergo treatment with HDMTX (\u2265 3 g/m\\^2) at the James Cancer Hospital",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "The Ohio State Comprehensive Cancer Center",
                    "role": "CONTACT",
                    "phone": "800-293-5066",
                    "email": "OSUCCCClinicaltrials@osumc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Narendranath Epperla, MD, MS",
                    "affiliation": "Ohio State University Comprehensive Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Ohio State University Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Narendranath Epperla, MD, MS",
                            "role": "CONTACT",
                            "phone": "614-688-7940",
                            "email": "Narendranath.Epperla@osumc.edu"
                        },
                        {
                            "name": "Narendranath Epperla, MD, MS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "The Jamesline",
                    "url": "http://cancer.osu.edu"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000016393",
                    "term": "Lymphoma, B-Cell"
                },
                {
                    "id": "D000016403",
                    "term": "Lymphoma, Large B-Cell, Diffuse"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "asFound": "B-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18831",
                    "name": "Lymphoma, Large B-Cell, Diffuse",
                    "asFound": "Diffuse Large B-Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "asFound": "B-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1866",
                    "name": "Diffuse Large B-Cell Lymphoma",
                    "asFound": "Diffuse Large B-Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4686",
                    "name": "Primary Central Nervous System Lymphoma",
                    "asFound": "Central Nervous System Lymphoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M11703",
                    "name": "Methotrexate",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}